Fereshteh Chekin

7PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicineNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 08, 2026
Functionalization of Mesoporous Carbon by Bovine Serum Albumin for Application in an Electrochemically Controlled Delivery System of Imatinib Anticancer Drug.

|Mar 16, 2026
The Efficacy of Palbociclib-Conjugated ZnO-Ordered Mesoporous Carbon Nanohybrid against MCF-7 Breast Cancer Cell Line.

Fatemeh Zahra Fallah Lajimi, Bahare Sabeti, Fereshteh Chekin

|May 31, 2025
Carbon nanotubes/ordered mesoporous carbon/chitosan nanocomposite as a promising carrier for everolimus targeted delivery toward lung cancer cells.

Ghazal Khodarahmi, Bahare Sabeti, Fereshteh Chekin

|Jan 08, 2025
Zinc oxide nanoparticles decorated nitrogen doped porous reduced graphene oxide-based hybrid to sensitive detection of hydroxychloroquine in plasma and urine.

Mohammad Amiri, Zahra Hashemi, Fereshteh Chekin

|Sep 12, 2024
An ordered mesoporous carbon-silica hybrid for the detection of the antiviral drug ribavirin in clinical samples.

Amir Hosein Ali Naghian, Zahra Hashemi, Fereshteh Chekin

|Jul 14, 2023
Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug.

Maral Mashreghi, Bahare Sabeti, Fereshteh Chekin

Pageof 2

Frequent Collaborators

2 joint publications

Bahare Sabeti

1 joint publications

Na'il Saleh